NEW YORK, Oct. 29 — Athersys and 3-Dimensional Pharmaceuticals on Monday announced a collaboration to discover and commercialize novel small-molecule pharmaceuticals for disease treatment. 

Terms of the deal call for Cleveland-based Athersys to use its functional genomics technology to complement 3-Dimensional Pharmaceuticals’ drug-development and optimization experience. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.